• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project
【24h】

Enhanced pharmacy services, barriers and facilitators in Australia's community pharmacies: Australia's National Pharmacy Database Project

机译：澳大利亚社区药房的增强药房服务，障碍和促进者：澳大利亚国家药房数据库项目

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective To report the frequency of 27 enhanced pharmacy services (EPS) provided in Australia's community pharmacies and to analyse barriers and facilitators for providing priority services. Setting A large representative sample of community pharmacies in Australia in 2002. Method Questionnaires were mailed to owners or managers of a stratified, representative sample of Australia's community pharmacies; 1131of 1391 consenting pharmacies responded (81.3%). Specifically trained staff, fees charged, structural and other components and plan to introduce EPS were analysed. The barriers and facilitators for all EPS were rated by a Likert scale. Logistic regression models tested for predictors for providing one or more EPS and those related to Australia's National Health Priorities. Key findings Eighty-eight per cent of Australia's community pharmacies offered >1 EPS. More than 40% offered EPS for asthma, diabetes, methadone, herbal medicines, hypertension and wound care. Pharmacies with higher turnover (odds ratio (OR), 1.90; 99% confidence interval (CI) = 1.05-3.42) and younger owners (OR for age, 0.69; 99% CI = 0.48-0.99) were predictors for providing >1 EPS. Higher turnover was a predictor for diabetes care. Enclosed counselling area was a predictor for hypertension care. Owners and managers committed to continuing education was a predictor for diabetes and hyperlipidaemia services. Significant barriers were perceived lack of confidence for diabetes care and not being regarded as 'part of the job' for asthma, diabetes, hypertension and weight-management services. Conclusion The percentages of pharmacies in Australia that provided equivalent EPS were similar or higher than the UK, New Zealand and USA. The frequency of existing and planned EPS appeared disproportionately low to satisfy national health priorities. Significant barriers and facilitators and pharmacy characteristics for providing EPS were identified. The results assist national bodies to increase the uptake of EPS by pharmacies.
机译：目的报告澳大利亚社区药房提供的27种增强药房服务（EPS）的频率，并分析提供优先服务的障碍和促进者。在2002年在澳大利亚建立了一个大型的代表性社区药房样本。方法将问卷调查表邮寄给澳大利亚社区药房的分层，代表性样本的所有者或经理。 1391个同意的药房中，有1131个做出了回应（81.3％）。分析了受过专门培训的人员，收取的费用，结构和其他组成部分以及引入EPS的计划。所有每股收益的障碍和促进因素均用李克特量表进行了评估。对逻辑回归模型进行了测试，以预测可提供一个或多个EPS以及与澳大利亚国家卫生优先级相关的EPS的预测因子。主要发现澳大利亚88％的社区药店的EPS均大于1。超过40％的人为哮喘，糖尿病，美沙酮，草药，高血压和伤口护理提供EPS。营业额较高（赔率（OR）为1.90; 99％置信区间（CI）= 1.05-3.42）和年轻业主（年龄为OR为0.69; 99％CI = 0.48-0.99）的药房是提供> 1 EPS的预测指标。更高的营业额是糖尿病护理的预测指标。封闭的咨询区是高血压护理的预测指标。致力于继续教育的所有者和管理者是糖尿病和高脂血症服务的预测指标。人们认为重大障碍使人们对糖尿病护理缺乏信心，也没有被视为哮喘，糖尿病，高血压和体重管理服务的“工作组成部分”。结论在澳大利亚，提供等效EPS的药房百分比与英国，新西兰和美国相近或更高。为了满足国家卫生优先重点，现有和计划中的EPS出现的频率显得过低。确定了提供EPS的重要障碍和促进者以及药房特征。结果有助于国家机构增加药房对EPS的吸收。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号